Speakers - Healthcare
The Diamond Jubilee Faculty Alumni Network (FAN) Symposium (US)
Date: Saturday, 13th October 2018
Prof. B. Ravi - Convener
Prof. B. Ravi heads E-Foundry and BETiC – Biomedical Engineering & Technology incubation Centre. In the last 25 years, he initiated several inter-disciplinary multi-institutional R&D projects, leading to indigenous products, startup companies and social impact. He guided the development of AutoCAST and FLOW+ software used in over 150 foundries and institutes. Ten medical devices developed in BETiC have been licensed to startups, industry or NGOs; these have won prestigious awards and touched many lives. Prof. Ravi shared the relevant knowledge and best practices through 250 technical papers, 300 invited talks/ conference presentations, and 60 training programmes. Several institutes have replicated E-foundry and BETiC cells. As a member of governing or advisory councils of various organizations, Prof. Ravi is also contributing to best practices and policies related to translational research and product innovation.
| Prof. Sanjeeva Srivastava - Co- Convener |
Associate Professor, Department of Biosciences and Bioengineering
Research Interests:Proteomics describes the study and characterization of complete set of proteins present in a cell, organ or organism at a given time. My laboratory is using high throughput proteomic techniques such as two-dimensional difference in gel electrophoresis, mass spectrometry and protein microarray etc. for biomarker discovery in cancer & tropical diseases of India such as malaria, to study protein-protein interactions and drug target discovery. Information obtained from research program is also used for studies and computing models to enhance our understanding in systems approach.
Prof. Anurag Mairal - Convener -US
Adjunct Professor, Medicine – Cardiovascular Medicine
Profile:Dr. Anurag Mairal is a Consulting Associate Professor of Medicine and the Director, Global Exchange Program at Stanford Byers Center for Biodesign, Stanford University. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs. He is part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, a graduate-level course offered to engineering, business, and medical students at Stanford University. He also has additional appointments as an Adjunct Professor at Stanford Graduate School of Business and Faculty Fellow at the Center for Innovation in Global Health. As a Co-Director of the India Biodesign Phase II initiative, he leads the Forum, a platform for supporting India's medtech entrepreneurs. As the Chair of a BME IDEA APAC, a new initiative to bring together medtech innovation programs in Asia Pacific region, he is focused on building a sustainable organization that supports the needs of innovation stakeholders in the region. Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry.
Dr. Mairal has an extensive background in medical technology development and commercialization, collaborating with partners in the U.S., India, China, and other emerging markets to advance product development, manufacturing, and distribution. Recently, he took two years off from Orbees Medical to take a senior leadership role at PATH, a major global health nonprofit based in Seattle. In this role, he oversaw research and development, commercialization, and implementation of technologies in PATH's medical devices, diagnostics, and digital health divisions. Previously, he held several positions at Johnson & Johnson, including Business Development Director and Product Director for structural heart, cardiology, and peripheral vascular products at Cordis. Before joining J&J, he was a Group Leader and a Process Development Manager at Membrane Technology and Research (MTR). At MTR, he was responsible for business development, strategic alliances, and product development in the bioseparations area. An active mentor to entrepreneurs and industry professionals, he serves on the boards of several for-profit and non-profit organizations and is a Charter Member at EPPIC Global Network.
Dr. Mairal earned a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the University of California at Berkeley. He also holds an MS in chemical engineering from the Indian Institution of Technology in Mumbai and a BS in chemical engineering from National Institute of Technology, Raipur. Dr. Mairal was a post-doctoral fellow at the University of Twente, Netherlands and at University of Michigan, Ann Arbor. Dr. Mairal has an MBA from the Haas School of Business at University of California, Berkeley. At Haas, he was a founding co-Chairman of the South Asia Business Conference and Chair of the Biotech Panel for the Asia Business Conference. His work has been published in more than 30 publications, and he has been issued seven patents.
Dr. Rajan Dewar - Co – Convener (US)
His residency and fellowship training in Anatomic and Clinical Pathology at Yale University School of Medicine and fellowships in Molecular Genetic Pathology & Hematopathology, which he completed in 2006. He joined as a faculty member at the Department of Pathology at Beth Israel Deaconess Medical Center, Boston & Instructor in Pathology of the Harvard Medical School in August 2006. He directed the automated hematology laboratory there for 9 years. He participated actively in medical student and resident teaching; He also developed research interests in Ph+ALL, bone marrow microenvironment and recently on cell of origin identification in Diffuse Large B-cell Lymphoma. While at Harvard, he graduated from the Global Health Delivery Intensive program, offered by the TH Chan Harvard School of Public Health and Harvard Medical School, and directed a program in global health for cancer screening in rural women in South India. He was also affiliate faculty of the Harvard Divinity School.
In September 2015, Dr. Dewar joined the faculty of the University of Michigan Department of Pathology as an Associate Professor. Currently, he serves as the Director of the hematology laboratories of the UMHS. He is the author of more than 75 peer-reviewed publications, book chapters, educational products and abstracts. Dr. Dewar has been an invited speaker at numerous local, national and international presentations. He is board certified in Anatomic and Clinical Pathology, Hematopathology and Molecular Genetic Pathology.
Dr. Ajit Singh - Guest of Honor
Profile:Ajit Singh focuses on early-stage Technology and Life Science investments. He currently represents Artiman on the Boards of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics and medECUBE. Ajit is also an Adjunct Professor in the School of Medicine at Stanford University and serves on the Board of Directors of Max Healthcare based in New Delhi, India. Prior to joining Artiman, Ajit was the President and CEO of BioImagene (acquired by Roche), a Digital Pathology company. Before BioImagene, Ajit spent nearly twenty years at Siemens in various roles, most recently as the Chief Executive Officer of the Digital Radiology and Medical Informatics business of Siemens Healthcare. Prior roles included President and CEO of the Oncology Care Systems Group, Group Vice President of Siemens e-Health, and Vice President of Siemens Health Services. From 1989 to 1995, he was at Siemens Corporate Research artificial intelligence, robotics, computer vision, and image analysis. During this time, he concurrently served on the faculty at Princeton University. Ajit has a Ph.D. in Computer Science from Columbia University, a master's degree in Computer Engineering from Syracuse University and a bachelor's degree in Electrical Engineering from Banaras Hindu University, India. He has published two books and numerous refereed articles, and holds five patents.
Prof. Raj Doshi - Panellist
Adjunct Professor, Medicine - Cardiovascular Medicine
Dr. Rajiv Doshi serves an Adjunct Professor of Medicine at Stanford University and as the Director of the India Program at the Byers Center for Biodesign. Dr. Doshi previously served as a Adjunct Professor of Business and Lecturer of Mechanical Engineering at Stanford University.
Dr. Doshi previously conceived of and served as Executive Director (US) of Stanford-India Biodesign. The goal of Stanford-India Biodesign was to train the next generation of medical technology innovators in India. Funded by the Government of India, the program was a first-of-its-kind collaboration between Stanford University, the Indian Institute of Technology (IIT) Delhi, and the All India Institute of Medical Sciences (AIIMS).
Dr. Doshi is also the Founder and CEO of Piper Biosciences, a Bay Area startup that is developing products that help manage chronic medical conditions through the integration of medically-proven dietary supplements with digital lifestyle modification.
Dr. Doshi serves as a Sr. Advisor to McKinsey & Co., helping healthcare companies define and conceptualize new medical products and business models for developed and emerging markets. Dr. Doshi serves on the Board of Directors of TEAMFund, an impact investment fund focused on medical technology innovation for India and Africa. He also serves as a pro bono advisor to a dozen India-based medical technology start-ups.
Dr. Doshi previously founded Ventus Medical, where he served as its first Chief Executive Officer. Dr. Doshi is the inventor of the core nasal EPAP technology of Ventus Medical’s products: for obstructive sleep apnea (Provent Sleep Apnea Therapy) and snoring (Theravent Snoring Therapy). Provent represented the first new class of obstructive sleep apnea therapy since CPAP.Dr. Doshi has roughly 70 US and international patents issued or pending. In 2012, Dr. Doshi was named by Forbes India as one of the top 18 Indian scientists who are changing the world. He is also the recipient of the Soros Fellowship
|Prof. Debjani Paul - Panellist|
Department of Biosciences and Bioengineering